Literature DB >> 16934062

Characterization of blood components prepared from whole-blood donations after a 24-hour hold with the platelet-rich plasma method.

Louis Thibault1, Annie Beauséjour, Marie Joëlle de Grandmont, Réal Lemieux, Jean-François Leblanc.   

Abstract

BACKGROUND: The preparation of platelet (PLT) concentrates (PCs) from PLT-rich plasma (PRP) requires that whole blood (WB) be processed within 8 hours of collection. Increasing WB storage time to 24 hours would be logistically attractive. This study compares the in vitro quality of blood components prepared from WB stored for 8 and 24 hours at room temperature before processing with the PRP method. STUDY DESIGN AND METHODS: WB units were collected from ABO-matched blood donors. To reduce individual variations, paired donations were drawn in parallel, pooled, and split back in the collection bag. One unit was held for 6 to 8 hours and the other for 22 to 24 hours at 20 to 24 degrees C. Prestorage leukoreduced components were prepared with the PRP as intermediate product and analyzed during storage.
RESULTS: RBC units prepared after an 8- or 24-hour hold were comparable in terms of hemolysis, sodium, pH, and ATP levels. RBC 2,3- diphosphoglycerate (2,3-DPG) was significantly lower in RBCs prepared from 24-hour hold donations immediately after processing but not after 20 days of storage. Residual white blood cells were approximately fivefold higher (p < 0.05) in 24-hour RBC units. For PCs, measurements for glucose, ATP, lactate, pH, extent of shape change, hypotonic shock response, and CD62p activation were similar. No differences were observed in the von Willebrand factor, factor (F)V, FVIII, and fibrinogen content of fresh-frozen plasma.
CONCLUSIONS: The decrease in FVIII and RBC 2,3-DPG can be acceptable as a compromise to improve blood component logistics, but leukoreduction efficiency must be improved before considering the adoption of an overnight storage of WB before PRP processing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16934062     DOI: 10.1111/j.1537-2995.2006.00894.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  8 in total

Review 1.  Transfusion-related red blood cell alloantibodies: induction and consequences.

Authors:  Christopher A Tormey; Jeanne E Hendrickson
Journal:  Blood       Date:  2019-02-26       Impact factor: 22.113

Review 2.  Understanding red blood cell alloimmunization triggers.

Authors:  Jeanne E Hendrickson; Christopher A Tormey
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

3.  Platelet concentrates prepared after a 20- to 24-hour hold of the whole blood at 22°C.

Authors:  Sherrill J Slichter; Jill Corson; Mary Kay Jones; Todd Christoffel; Esther Pellham; Doug Bolgiano
Journal:  Transfusion       Date:  2012-02-10       Impact factor: 3.157

Review 4.  Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models.

Authors:  Alex B Ryder; James C Zimring; Jeanne E Hendrickson
Journal:  Transfus Med Hemother       Date:  2014-11-17       Impact factor: 3.747

5.  Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation.

Authors:  Luc H Boudreau; Anne-Claire Duchez; Nathalie Cloutier; Denis Soulet; Nicolas Martin; James Bollinger; Alexandre Paré; Matthieu Rousseau; Gajendra S Naika; Tania Lévesque; Cynthia Laflamme; Geneviève Marcoux; Gérard Lambeau; Richard W Farndale; Marc Pouliot; Hind Hamzeh-Cognasse; Fabrice Cognasse; Olivier Garraud; Peter A Nigrovic; Helga Guderley; Steve Lacroix; Louis Thibault; John W Semple; Michael H Gelb; Eric Boilard
Journal:  Blood       Date:  2014-07-31       Impact factor: 22.113

6.  The how's and why's of evidence based plasma therapy.

Authors:  Mark H Yazer
Journal:  Korean J Hematol       Date:  2010-09-30

Review 7.  Quality Assessment of Established and Emerging Blood Components for Transfusion.

Authors:  Jason P Acker; Denese C Marks; William P Sheffield
Journal:  J Blood Transfus       Date:  2016-12-14

8.  Red blood cell alloimmunization and sickle cell disease: a narrative review on antibody induction.

Authors:  Jeanne E Hendrickson
Journal:  Ann Blood       Date:  2020-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.